It was suggested that neutralizing antibodies induced by SARS-CoV-2 infection, especially those directed to the epitopes present in the S protein, plays a crucial role in controlling viral infection and preventing reinfections [77] and are the principle of protection, resulting from convalescent plasma treatments [78]. This evidence concerns the gene PROS1 and viral infectious disease.